Adherence to Pre-exposure Prophylaxis in Black Men Who Have Sex with Men and Transgender Women in a Community Setting in Harlem, NY.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 10 5 2020
medline: 20 11 2020
entrez: 10 5 2020
Statut: ppublish

Résumé

While oral pre-exposure prophylaxis (PrEP) has proven efficacious for HIV prevention, consistent use is necessary to achieve its intended impact. We compared effectiveness of enhanced PrEP (enPrEP) adherence support to standard of care (sPrEP) among Black MSM and TGW attending a community clinic in Harlem, NY. EnPrEP included peer navigation, in-person/online support groups, and SMS messages. Self-reported adherence over previous 30 days, collected in quarterly interviews, was defined as ≥ 57%. Crude and adjusted analyses examined factors associated with adherence. A total of 204 participants were enrolled and randomized; 35% were lost to follow-up. PrEP adherence was 30% at 12-months; no intervention effect was observed (p = 0.69). Multivariable regression analysis found that lower adherence was associated with low education and depressive symptoms. We found that an enhanced adherence intervention did not improve PrEP adherence. Findings point to the need for innovative methods to improve PrEP adherence among Black MSM and TGW.Clinical Trial Registration NCT02167386, June 19, 2014.

Identifiants

pubmed: 32385678
doi: 10.1007/s10461-020-02901-6
pii: 10.1007/s10461-020-02901-6
doi:

Substances chimiques

Anti-HIV Agents 0

Banques de données

ClinicalTrials.gov
['NCT02167386']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

3436-3455

Subventions

Organisme : Foundation for the National Institutes of Health
ID : R01MH098723
Organisme : Gilead Sciences
ID : CO-US-164-0471

Auteurs

P W Colson (PW)

Harlem Prevention Center, ICAP at Columbia University, New York, USA. Pwc2@columbia.edu.

J Franks (J)

Harlem Prevention Center, ICAP at Columbia University, New York, USA.

Y Wu (Y)

Harlem Prevention Center, ICAP at Columbia University, New York, USA.

F S Winterhalter (FS)

Harlem Prevention Center, ICAP at Columbia University, New York, USA.

J Knox (J)

Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, USA.

H Ortega (H)

Harlem Prevention Center, ICAP at Columbia University, New York, USA.

W M El-Sadr (WM)

Harlem Prevention Center, ICAP at Columbia University, New York, USA.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA.

Y Hirsch-Moverman (Y)

Harlem Prevention Center, ICAP at Columbia University, New York, USA.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH